Use this dropdown to select your preferred language.
JTI (Japan Tobacco International) is a global company driven by quality and innovation, caring for its people, adult consumers, and the world we share. Founded in 1999 as a subsidiary of JT Inc., JTI employs over 46,000 people of 128 nationalities and operates in 130+ markets. Our purpose is Creating fulfilling moments. Creating a better future.
JTI (Japan Tobacco International) is a global company driven by quality and innovation, caring for its people, adult consumers, and the world we share. Founded in 1999 as a subsidiary of JT Inc., JTI employs over 46,000 people of 128 nationalities and operates in 130+ markets. Our purpose is Creating fulfilling moments. Creating a better future.
Angelini Pharma è la società farmaceutica delle Angelini Industries. Siamo un’azienda farmaceutica integrata con ampi programmi di ricerca e sviluppo, produzione di livello mondiale e solide capacità commerciali. Ci impegniamo ad aiutare i pazienti a combattere le malattie con particolare attenzione alla salute mentale, all’epilessia, alle malattie rare e all’assistenza sanitaria per i consumatori.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company operates across Specialty and Primary Care areas and is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.
The company operates directly in 20 countries employing more than 2,700 people, and commercializes its products in more than 70 countries through strategic alliances with leading international pharmaceutical groups.
Over the years, the Research and Development teams at Angelini Pharma discovered and developed several important molecules, among which trazodone and benzydamine. Currently, the programs of research, development, and innovation focus on Brain Health, particularly Mental Health and Epilepsy.